GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cell Biotech Co Ltd (XKRX:049960) » Definitions » Shiller PE Ratio

Cell Biotech Co (XKRX:049960) Shiller PE Ratio : (As of Jan. 19, 2025)


View and export this data going back to 2002. Start your Free Trial

What is Cell Biotech Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Cell Biotech Co Shiller PE Ratio Historical Data

The historical data trend for Cell Biotech Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cell Biotech Co Shiller PE Ratio Chart

Cell Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.12 15.23 11.26 7.10 6.18

Cell Biotech Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.11 6.18 6.53 - -

Competitive Comparison of Cell Biotech Co's Shiller PE Ratio

For the Biotechnology subindustry, Cell Biotech Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Biotech Co's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cell Biotech Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Cell Biotech Co's Shiller PE Ratio falls into.



Cell Biotech Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Cell Biotech Co's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Cell Biotech Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=142/*
=

Current CPI (Sep. 2024) = .

Cell Biotech Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 444.000 99.098 0.000
201503 224.000 99.720 0.000
201506 558.000 100.050 0.000
201509 913.000 100.110 0.000
201512 565.000 100.220 0.000
201603 633.000 100.560 0.000
201606 625.000 100.790 0.000
201609 397.000 101.460 0.000
201612 665.000 101.560 0.000
201703 451.000 102.850 0.000
201706 922.000 102.610 0.000
201709 655.000 103.490 0.000
201712 389.000 102.990 0.000
201803 675.000 104.100 0.000
201806 664.000 104.130 0.000
201809 520.000 105.650 0.000
201812 724.000 104.350 0.000
201903 294.000 104.490 0.000
201906 269.000 104.880 0.000
201909 226.000 105.200 0.000
201912 184.000 105.120 0.000
202003 424.000 105.540 0.000
202006 67.000 104.870 0.000
202009 159.000 106.200 0.000
202012 -200.000 105.765 0.000
202103 390.000 107.357 0.000
202106 114.000 107.579 0.000
202109 550.000 108.759 0.000
202112 414.000 109.676 0.000
202203 434.000 111.806 0.000
202206 460.000 114.083 0.000
202209 803.000 114.831 0.000
202212 -498.000 115.200 0.000
202303 417.000 116.550 0.000
202306 -324.000 117.140 0.000
202309 433.000 119.111 0.000
202312 395.000 118.848 0.000
202403 477.000 118.848 0.000
202406 590.000 0.000
202409 142.000 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cell Biotech Co  (XKRX:049960) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Cell Biotech Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Cell Biotech Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cell Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
134 Gaegok-ri, Wolgot-myeon, Gimpo-si, Gyeonggi-Do, KOR, 415-872
Cell Biotech Co Ltd is a specialized biotech company. It is engaged in the fermentation and coating technology development as well as manufacturing probiotics and lactic acid bacteria. The key product consists Probiotic DUOLAC, Nutra DUOLAC, LACTOClear, and LAB2PRO. The company distributes its products within domestic market and to overseas markets.

Cell Biotech Co Headlines

No Headlines